Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4271420 | 0.84 | CYP19A1 (0.35) | CYP19A1 | |
| SCHEMBL4266616 | 0.82 | CYP19A1 (0.30) | CYP19A1 | |
| SCHEMBL4277408 | 0.82 | — | — | |
| SCHEMBL4278987 | 0.81 | CYP19A1 (0.37) | CYP19A1 | |
| SCHEMBL4281128 | 0.80 | — | — | |
| SCHEMBL4276445 | 0.80 | KDM4E (0.31) | — | |
| SCHEMBL4274414 | 0.79 | — | — | |
| SCHEMBL4269311 | 0.79 | — | — | |
| SCHEMBL4269538 | 0.79 | — | — | |
| SCHEMBL4277381 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475256-B1 | DEHYDROGENATION REACTION | FIRMENICH & CIE (CH) | 2024-01-24 | — | — | EP | disclosed |
| CN-109415293-B | Dehydrogenation reaction | 弗门尼舍有限公司 | 2022-08-02 | — | — | CN | disclosed |
| US-10899694-B2 | Dehydrogenation reaction | FIRMENICH SA (CH) | 2021-01-26 | — | — | US | disclosed |
| US-20190345088-A1 | DEHYDROGENATION REACTION | FIRMENICH SA (CH) | 2019-11-14 | — | — | US | disclosed |
| EP-3475256-A1 | DEHYDROGENATION REACTION | Firmenich SA (CH) | 2019-05-01 | — | — | EP | disclosed |
| WO-2018001963-A1 | DEHYDROGENATION REACTION | FIRMENICH SA (CH) | 2018-01-04 | — | — | WO | disclosed |
| EP-2622051-B1 | 4,4-DIMETHYL-DECAL-1-ONE OR -1-OL DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH & CIE (CH) | 2014-07-09 | — | — | EP | disclosed |
| US-8697626-B2 | 4,4-dimethyl-decal-1-one or -1-OL derivatives as perfuming ingredients | FIRMENICH SA (CH) | 2014-04-15 | — | — | US | disclosed |
| EP-2622051-A1 | 4,4-DIMETHYL-DECAL-1-ONE OR -1-OL DERIVATIVES AS PERFUMING INGREDIENTS | Firmenich SA (CH) | 2013-08-07 | — | — | EP | disclosed |
| US-20130190218-A1 | 4,4-DIMETHYL-DECAL-1-ONE OR -1-OL DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH SA | 2013-07-25 | — | — | US | disclosed |
| US-20070066654-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | KOYAMA SHOZO | 2007-03-22 | — | — | US | disclosed |
| EP-0780122-B1 | DEPRESSANT OF FUNCTIONS DEVELOPED BY MOLECULE | KOYAMA SHOZO (JP) | 2006-11-22 | — | — | EP | disclosed |
| US-20040224926-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | KOYAMA SHOZO (JP) | 2004-11-11 | — | — | US | disclosed |
| US-6710090-B2 | A CYCLOHEX-1-EN-2-ONE COMPOUND | KOYAMA SHOZO (JP) | 2004-03-23 | — | — | US | disclosed |
| US-20020165206-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | KOYAMA SHOZO (JP) | 2002-11-07 | — | — | US | disclosed |
| US-6346551-B1 | ANTIBACTERIAL, ANTIFUNGAL, ANTIVIRAL, BACTERICIDAL AND/OR STERILIZATION AGENTS, ANTICANCER DRUGS, BLOOD COAGULATION AND FIBRINOLYSIS INHIBITORS AND/OR BLOCKING AGENTS, INHIBITORY AND/OR BLOCKING AGENTS OF ANTIGEN-ANTIBODY REACTIONS | KOYAMA SHOZO (JP) | 2002-02-12 | — | — | US | disclosed |
| EP-0780122-A1 | DEPRESSANT OF FUNCTIONS DEVELOPED BY MOLECULE | Koyama, Shozo (JP) | 1997-06-25 | — | — | EP | disclosed |
| EP-0455304-B1 | Process for the preparation of cyclic ketones | SHELL INT RESEARCH (NL) | 1994-12-07 | — | — | EP | disclosed |
| US-5124486-A | PROCESS FOR THE PREPARATION OF CYCLIC KETONES | SHELL RESEARCH LIMITED (GB) | 1992-06-23 | — | — | US | disclosed |
| EP-0455304-A1 | Process for the preparation of cyclic ketones | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066654-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | CD47, SERPINB6, CD74 | CYP19A1 2046/4885 |
| US-20020165206-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | CD69, TFPI, SERPINE1 | CYP19A1 293/4885 |
| US-20040224926-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | CD47, MCL1, CD74 | CYP19A1 1601/4885 |
| US-10899694-B2 | Dehydrogenation reaction | PDK3, PDK2, PDHA1 | CYP19A1 185/4885 |
| US-20190345088-A1 | DEHYDROGENATION REACTION | PDK3, PDK2, PDHA1 | CYP19A1 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.